Trial · NCT07555938
Registered outcomes30
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 30
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Minimal Residual Disease (MRD)-Negative Complete Response (CR) Rate | Up to 1 year after the last participant is randomized | |
| Primary | Progression-Free Survival (PFS) | Up to 5 years after the last participant is randomized | |
| Secondary | Very Good Partial Response (VGPR) or Better Rate | Up to 5 years after the last participant is randomized | |
| Secondary | Overall Survival (OS) | Up to 5 years after the last participant is randomized | |
| Secondary | Change in Disease Symptoms as Assessed by the European Organization for Research and Treatment of Cancer Quality-of-life Questionnaire (EORTC QLQ)-Multiple Myeloma Module 20 (MY20) | From baseline to Month 6 | Primary domains: fatigue, pain, physical functioning, cognitive functioning and global health status. |
| Secondary | Overall Response Rate (ORR) | Up to 5 years after the last participant is randomized | |
| Secondary | Complete Response (CR) Rate | Up to 5 years after the last participant is randomized | |
| Secondary | Time to Response (TTR) | Up to 5 years after the last participant is randomized | |
| Secondary | Time to Best Response (TTBR) | Up to 5 years after the last participant is randomized | |
| Secondary | Duration of Response (DOR) | Up to 5 years after the last participant is randomized | |
| Secondary | Progression-Free Survival (PFS) | Up to 5 years after the last participant is randomized | |
| Secondary | Progression-Free Survival 2 (PFS2) | Up to 5 years after the last participant is randomized | |
| Secondary | Overall MRD-Negative Complete Response Rate | Up to 5 years after the last participant is randomized | |
| Secondary | Overall MRD-Negative Rate | Up to 5 years after the last participant is randomized | |
| Secondary | Sustained MRD-Negative CR Rate | At 6, 12, and 24 months | |
| Secondary | Percentage of Participants With Adverse Events (AEs) | Up to 5 years after the last participant is randomized | |
| Secondary | Tolerability as Assessed by the Incidence of Dose Interruptions, Dose Reductions, Dose Intensity, and Treatment Discontinuation | Up to 5 years after the last participant is randomized | |
| Secondary | Number of Participants With Presence, Frequency of Occurrence, Severity, and/or Degree of Interference With Daily Function of Shortness of Breath, Cough, Heart Palpitations, Rash, Dizziness, and Nausea Assessed NCI PRO-CTCAE | Up to 5 years after the last participant is randomized | |
| Secondary | Change From Baseline in Shortness of Breath, Cough, Heart Palpitations, Rash, Dizziness, and Nausea Assessed by the National Cancer Institute Patient Reported Outcomes Common Terminology Criteria for Adverse Events (NCI PRO-CTCAE) | Baseline and up to 5 years after the last participant is randomized | |
| Secondary | Change From Cycle 1 Day 8 in Treatment-Related Side Effect Bother as Assessed by the Functional Assessment of Cancer Therapy-General, General Population 5 (FACTG GP5) | At Day 8 of Cycle 1, up to 5 years after the last participant is randomized. Cycle 1 is 21 days. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07555938/registered